Impaired wound healing predisposes obese mice to severe influenza virus infection

Journal of Infectious Diseases

Volumn 205, Issue 2, 2012, Pages 252-261

  O'Brien, Kevin B ^a,b   Vogel, Peter ^b   Duan, Susu ^b   Govorkova, Elena A ^b   Webby, Richard J ^b   McCullers, Jonathan A ^b   Schultz Cherry, Stacey ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

2009 H1N1 INFLUENZA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; HIGH RISK POPULATION; HISTOPATHOLOGY; HONG KONG INFLUENZA; INFECTION SENSITIVITY; LUNG EDEMA; LUNG INJURY; LUNG PARENCHYMA; MALE; MORTALITY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SURVIVAL; WOUND HEALING IMPAIRMENT;

ALBUMINS; ANIMALS; ANTIVIRAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LEUKOCYTE COUNT; LUNG; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MONOCYTES; NEUTROPHIL INFILTRATION; OBESITY; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR; PULMONARY EDEMA; SEVERITY OF ILLNESS INDEX; VIRAL LOAD; WOUND HEALING;

EID: 84555186972     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir729     Document Type: Article

References (44)

1. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201.
2. Presanis AM, De Angelis D, Hagy A, et al. The severity of pandemic H1N1 influenza in the United states, from April to July 2009: a Bayesian analysis. PLoS Med 2009; 6:e1000207.
3. Diaz E, Rodriguez A, Martin-Loeches I, et al. Impact of obesity in patients infected with new influenza A (H1N1). Chest 2011; 139:382-386.
4. Gerardin P, El Amrani R, Cyrille B, et al. Low clinical burden of 2009 pandemic influenza A (H1N1) infection during pregnancy on the island of La Reunion. PLoS One 2010; 5:e10896.
5. Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med 2010; 38:e91-7.
6. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302:1896-02.
7. Tsatsanis C, Margioris AN, Kontoyiannis DP. Association between H1N1 infection severity and obesitydadiponectin as a potential etiologic factor. J Infect Dis 2010; 202:459-60.
8. Gill JR, Sheng ZM, Ely SF, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010; 134:235-43.
9. Bautista E, Chotpitayasunondh T, Gao Z, et al. Clinical Aspects of pandemic 2009 influenza A (H1N1) virus infection. New Engl J Med 2010; 362:1708-19.
10. James WP. The fundamental drivers of the obesity epidemic. Obes Rev 2008; 9(suppl 1):6-13. (Pubitemid 351643184)
11. James WP. WHO recognition of the global obesity epidemic. Int J Obes (Lond) 2008; 32(suppl 7):S120-6.
12. Despres JP. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. J Endocrinol Invest 2006; 29:77-82.
13. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444:881-7. (Pubitemid 46024995)
14. Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, Despres JP. Visceral obesity and the heart. Int J Biochem Cell Biol 2008; 40:821-36.
15. Shore SA. Obesity, airway hyperresponsiveness, and inflammation. J Appl Physiol 2010; 108:735-43.
16. Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009; 14: pii 19309.
17. Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, McCullers JA. N-linked glycosylation attenuates H3N2 influenza viruses. J Virol 2007; 81:8593-600. (Pubitemid 47242833)
18. Carlson CM, Turpin EA, Moser LA, et al. Transforming growth factorbeta: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis. PLoS Pathog 2010; 6:e1001136.
19. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493-7.
20. Govorkova EA, Ilyushina NA, McClaren JL, Naipospos TS, Douangngeun B, Webster RG. Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model. Antimicrob Agents Chemother 2009; 53:3088-96.
21. Karlsson EA, Beck MA. The burden of obesity on infectious disease. Exp Biol Med (Maywood) 2010; 235:1412-24.
22. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182:311-22. (Pubitemid 30054364)
23. WilsonMR, O'Dea KP, Dorr AD, YamamotoH, GoddardME, Takata M. Efficacy and safety of inhaled carbon monoxide during pulmonary inflammation in mice. PLoS One 2010; 5:e11565.
24. Inouey BE, Daniloff E, Kohno N, Hiwada K, Newman LS. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med 1997; 156:109-15. (Pubitemid 27293174)
25. Smith JR, Ariano RE, Toovey S. The use of antiviral agents for the management of severe influenza. Crit Care Med 2010; 38:e43-51.
26. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303:235-41.
27. Sherry B, Blanck HM, Galuska DA, Pan L, Dietz WH, Balluz L. Vital signs: state-specific obesity prevalence among adultsdUnited States 2009. MMWR Morb Mortal Wkly Rep 2010; 59:1-5.
28. Huttunen R, Syrjanen J. Obesity and the outcome of infection. Lancet Infect Dis 2010; 10:442-3.
29. Nave H, Beutel G, Kielstein JT. Obesity-related immunodeficiency in patients with pandemic influenza H1N1. Lancet Infect Dis 2011; 11:14-5.
30. Easterbrook JD, Dunfee RL, Schwartzman LM, et al. Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus. Influenza Other Respi Viruses 2011; 5:418-425.
31. Strandberg L, Verdrengh M, Enge M, et al. Mice chronically fed highfat diet have increased mortality and disturbed immune response in sepsis. PLoS One 2009; 4:e7605.
32. Webb SR, Loria RM, Madge GE, Kibrick S. Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. J Exp Med 1976; 143:1239-48.
33. Smith AG, Sheridan PA, Harp JB, Beck MA. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 2007; 137:1236-43. (Pubitemid 46701917)
34. Smith AG, Sheridan PA, Tseng RJ, Sheridan JF, Beck MA. Selective impairment in dendritic cell function and altered antigen-specific CD81 T-cell responses in diet-induced obese mice infected with influenza virus. Immunology 2009; 126:268-79.
35. Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity in mice reduces the maintenance of influenza-specific CD81 memory T cells. J Nutr 2010; 140:1691-7.
36. Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J Immunol 2010; 184:3127-33.
37. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res 2010; 89:219-29.
38. Holcomb VB, Keck VA, Barrett JC, Hong J, Libutti SK, Nunez NP. Obesity impairs wound healing in ovariectomized female mice. In Vivo 2009; 23:515-8.
39. Tanigawa T, Watanabe T, Otani K, et al. Leptin promotes gastric ulcer healing via upregulation of vascular endothelial growth factor. Digestion 2010; 81:86-95.
40. Falagas ME, Athanasoulia AP, Peppas G, Karageorgopoulos DE. Effect of body mass index on the outcome of infections: a systematic review. Obes Rev 2009; 10:280-9.
41. Pai MP, Bearden DT. Antimicrobial dosing considerations in obese adult patients. Pharmacotherapy 2007; 27:1081-91.
42. Yokoyama T, Tsushima K, Ushiki A, et al. Acute lung injury with alveolar hemorrhage due to a novel swine-origin influenza A (H1N1) virus. Intern Med 2010; 49:427-30.
43. Bearman GM, Shankaran S, Elam K. Treatment of severe cases of pandemic (H1N1) 2009 influenza: review of antivirals and adjuvant therapy. Recent Pat Antiinfect Drug Discov 2010; 5:152-6.
44. Lee EH, Wu C, Lee EU, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis 2010; 50:1498-504.